- Investing Ideas
- U.S. Pharmaceuticals & Biotech Blue chip stocks
U.S. Pharmaceuticals & Biotech Blue chip stocks
Results
16
16 companies
Axsome Therapeutics
Market Cap: US$13.0b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$252.16
7D
2.4%
1Y
145.1%
Ionis Pharmaceuticals
Market Cap: US$12.1b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$74.31
7D
1.4%
1Y
100.8%
Elanco Animal Health
Market Cap: US$12.1b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$23.39
7D
2.3%
1Y
75.5%
Waters
Market Cap: US$35.4b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$357.00
7D
-1.7%
1Y
5.2%
Natera
Market Cap: US$32.4b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$226.44
7D
3.3%
1Y
32.4%
Insmed
Market Cap: US$20.7b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$98.45
7D
7.2%
1Y
-1.0%
BioMarin Pharmaceutical
Market Cap: US$10.7b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$55.02
7D
-2.0%
1Y
-0.4%
Madrigal Pharmaceuticals
Market Cap: US$11.6b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$499.86
7D
6.1%
1Y
76.8%
Alnylam Pharmaceuticals
Market Cap: US$37.6b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$282.72
7D
-2.9%
1Y
-9.5%
Viatris
Market Cap: US$18.7b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$15.73
7D
-0.3%
1Y
79.4%
Jazz Pharmaceuticals
Market Cap: US$14.2b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$226.93
7D
-1.2%
1Y
109.7%
BeOne Medicines
Market Cap: US$29.3b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$262.68
7D
-0.4%
1Y
3.9%
Royalty Pharma
Market Cap: US$31.2b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$53.70
7D
-1.5%
1Y
53.8%
Neurocrine Biosciences
Market Cap: US$15.7b
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
NBIX
US$159.00
7D
-1.2%
1Y
24.9%
Merck
Market Cap: US$284.4b
Operates as a healthcare company worldwide.
MRK
US$115.44
7D
-3.1%
1Y
45.6%
Gilead Sciences
Market Cap: US$158.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$125.45
7D
3.3%
1Y
16.2%